Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion evidence source_evidence_literature NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion SIO_000772 18159113 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion wasDerivedFrom befree-2016 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion wasGeneratedBy ECO_0000203 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- befree-2016 importedOn "2016-02-19" NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.